Documente Academic
Documente Profesional
Documente Cultură
*DR. PRASANNA B
INTRODUCTION
3
Causes and Effects in Standardization of aetiologies of the different systems of
Ayurvedic Drugs: medicines in Ayurvedic and Allopathic.
The term Ayurvedic drugs, comprises of, Why only Ayurvedic drug is targeted? No
herbal mineral animal resources other traditional system is commented in
substances broadly the standardisation of the parallel manner. May be, this is a
Ayurvedic drugs – based upon widely accepted medicine and has a wide
application. Can anyone test the allopathic
1. Collection of the herbs in proper season medicines with Ayurvedic science & its
and time, 2. Part of the herb or plant that is standards? Or scientific techniques? Hence
used and 3. The processing of that herb the slogan should be revised and replaced
into powder, or extract or any other forms, as “maintenance of standards” and quality
4. To be mixed in what order, with what control of Ayurvedic drugs which can be
ingredient etc were very clearly and achieved if the attempt is in the right
thoroughly described. direction. There is a factor called
Invariably, when everything is written in Idiosyncrasy- procedural and experimental
textbook and if it is not followed by some errors to give an accurate method in
unauthorized and unqualified evaluation.
manufacturers, how can anyone blame the Modern & authorized scientists can come
Ayurvedic drugs and its science along with forward with an exclusive analytical and
its philosophy? Today all are trying to evaluative methods for Ayurvedic drugs
judge the standards with procedures fixed preferably with innovative genuine
for another system of medicines – which is methods rather than trying to compare
not correct. Formulation and preparation with methods that are not suitable to
of medicines is based on the aetiology of Ayurvedic drugs. The standardisation
the disease and the formulations were methods of Ayurvedic drugs should be
designed accordingly. Fundamentally relevant and also evaluative.
there is a vast difference viz in the
4
BRIEF OVERVIEW OF THE PROCESS OF STANDARDIZATION
1. Passport data of raw plant drugs GSL (Good survey of Follow define GMP
literature)
2. Correct taxonomic identification GAP (Good agricultural Toxicity evaluation
and authentication practice)
3. Study on the medicinal part: root, GCP (Good clinical Chemical profiling
stem, bark, etc. practice)
4. Collection details: location, stage GHP (Good harvesting Pharmacodynamics
and development, time storage /handling practice)
etc.
5. Organoleptic evaluation of raw GLP (Good laboratory Pharmacokinetics
drug practice)
6. Microscopic and molecular GMP (Good Posology
examination manufacturing practice)
7. Chemical composition GMT (Good marketing Stability
technique)
8. Biological activity of whole plant - Presentation &
Packing
9. Shelf life of raw drugs - Therapeutic merits
5
Standardization of herbal drugs
QUALITY EVALUATION OF
HERBAL DRUGS
6
Macroscopic
evaluation
Total Ash
Moisture Value
Foreign
Heavy metals
content matter
Microscopic
evaluation
Specific gravity
Pharmacopoeial Standards
7
GENETIC MARKER techniques will serve as a rapid and
Some commonly used types of genetic specific tool in the herbal research,
markers are thereby, allowing the manufacturers to set
RFLP (or Restriction fragment length
quality standards and specifications. It is
polymorphism)
AFLP (or Amplified fragment length required to have all the crucial knowledge
polymorphism) of the particular drug in respect to various
RAPD (or Random amplification of parameters while developing an herbal
polymorphic DNA) drug formulation.
VNTR (Variable number tandem repeat)
MSP (Micro satellite polymorphism) Drug standardization has not only to
SNP (or Single nucleotide polymorphism) establish reasonable analytical methods for
STR (or Short tandem repeat) analyzing the active constituents, but many
SFP (or Single feature polymorphism) other factors should be concerned, so as to
seek marketing approval from regulatory
BIOLOGICAL PARAMETERS:
Bitterness value: unit equivalent authorities or scientific bodies for
bitterness of standard solution of Quinine therapeutic efficacy, safety and shelf- life
HCl. of herbal drugs. As well as to conduct or
Hemolytic property: by comparison with sponsor evaluative studies of their toxicity,
standard reference solution of saponin acceptability, cost and relative value
Astringent property: tannins that bind to compared with other drugs used in modern
standard Frieberg Hide powder
Swelling index: in water medicine. In this field, WHO guidelines
Foaming index: foam height produced by are intended to facilitate development in
1g material under specified conditions the herbal industry and for the assessment
and registration of such products.
TOXICOLOGICAL PARAMETERS:
Although there are a number of
These include the various identification standardization techniques available till
procedures: date but there is still lot to explore on the
Pesticide residues: including total organic subject of standardization of the herbal
chloride and total organic phosphorus
drugs and new approaches are demanded
Heavy metals: like Arsenic, cadmium,
mercury and lead in order to completely explore the
Microbial contaminations: total viable standardization of herbal drugs.
aerobic count of pathogens; viz. E. Coli,
Salmonella, P. aeruginosa, S. aureous etc. Hence, it is our prime duty to prove the
Aflatoxins: by TLC using standard efficacy and the power of Ayurvedic drugs
Aflatoxins (B1, B2, G1 and G2) to the society in the way in which they will
Radioactive contaminations. be accepted by all. India can emerge as the
major country and play the lead role in
production of standardized therapeutically
CONCLUSION
effective Ayurvedic formulations.
Standardization of herbal drugs is essential
This can be achieved only if the herbal
in order to assess the quality of drugs,
products are evaluated and analyzed using
based on the concentration of their active
sophisticated modern techniques of
principles. The advancement of analytical
standardization.
8
REFERENCES Anonymous. „Indian Pharmacopoeia‟
Controller of Publication, Delhi, Vol. II,
Mukherjee, P.W. Quality Control of 1996.
Herbal Drugs: An Approach to Evaluation
of Botanicals. Business Horizons Anonymous. The International
Publishers, New Delhi, India, 2002. Pharmacopeia, General Methods of
Analysis, 3rd edn. World Health
Rangari, V.D., Text book of Organization, Geneva. 1, 1979.
Pharmacognosy & Phytochemistry Vol. I,
Carrier Pub., 2006. Anonymous. General Guidelines for
Methodologies on Research and
Shinde M.V., Dhalwal K., Potdar K., Evaluation of Traditional Medicine. World
Mahadik K. Application of quality control Health Organization, Geneva, 2000.
principles to herbal drugs. International
Journal of Phytomedicine 1(2009) Kumar T. Standardization of Herbal
Drugs – A Review. Int J Uni Pharm Bio
WHO. Quality Control Methods for Sci, 2013.
Medicinal Plant Materials, World Health
Organization, Geneva, 1998. Patwekar SL, Suryawanshi AB,
Gaikwad MS, Pedewad SR, Potulwar AP.
WHO. Guidelines for the Appropriate Standardization of herbal drugs: An
Use of Herbal Medicines. WHO Regional overview. The Pharm Innovation J, 2015.
Publications, Western Pacific Series No 3,
WHO Regional office for the Western Vickers A, Zollman C. Herbal
Pacific, Manila, 1998. medicine. West J Med, 2001; 175: 125-8.
12. Sahoo N. Herbal drugs: standards and
Ekor M. The growing use of herbal regulation. Fitoterapia, 2010.
medicines: issues relating to adverse
reactions and challenges in monitoring Zhang J, Wider B, Shang H, Li X,
safety. Front Pharmacol, 2013. Ernst E. Quality of herbal medicines:
challenges and solutions. Complement
Sasidharan S, Chen Y, Saravanan D, Ther Med, 2012.
Sundram KM, Yoga Latha L. Extraction,
isolation and characterization of bioactive Calixto JB. Efficacy, safety, quality
compounds from plants' extracts. Afr J control, marketing and regulatory
Tradit Complement Altern Med, 2011. guidelines for herbal medicines
(phytotherapeutic agents). Braz J Med Biol
Garg V1, Dhar VJ, Sharma A, Dutt R. Res, 2000.
Facts about standardization of herbal
medicine: a review. Zhong Xi Yi Jie He Evans WC. „Trease and Evans
Xue Bao, 2012. Pharmacognosy‟ W.B. Saunders,
Edinburg, London, 15th Edn, 2002; 74-81.
Boyle SP, Doolan PJ, Andrews CE, 17. Handa SS, Rakesh DD, Vasisht K.
Reid RG. Evaluation of quality control „Compendium of Medicinal and Aromatic
strategies in Scutellaria herbal medicines. J Plants‟ Asia, ICS UNIDO, Ist Edn, 2006.
Pharm Biomed Anal, 2011.